This archive contains the following articles listed by volume, issue and page number:

Volume 9, 2005 Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2005 Pg. 2	PreScription: CompoundingToday.com and Sources of Compounding Chemicals Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 5-6	Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY Author(s): Reed-Kane Dana
Jan/Feb 2005 Pg. 6-8	Literature Reviews Author(s): Foy Elizabeth, MacCara Mary E
Jan/Feb 2005 Pg. 11-13	USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing Author(s): Caputo Ross A, Huffman Anne, Reich Robert
Jan/Feb 2005 Pg. 15-21	Using ACDs in the Practice of Pharmacy Author(s): Kastango Eric S
Jan/Feb 2005 Pg. 23-28	USP Chapter <797> and Preparing for a JCAHO Survey Author(s): McElhiney Linda F
Jan/Feb 2005 Pg. 29-31	Questions and Answers: USP Chapter <797> and JCAHO Compliance Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 33-35	A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In? Author(s): Vandenbroucke Johan, Rahe Hank
Jan/Feb 2005 Pg. 37-38	The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime Author(s): Wills Daniel
Jan/Feb 2005 Pg. 42-43	Defining Success Author(s): Roberts Jerrod L
Jan/Feb 2005 Pg. 44-46	The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Author(s): Allen Loyd V Jr, Ashworth Lisa D
Jan/Feb 2005 Pg. 47-49	Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations Author(s): Kupiec Thomas C
Jan/Feb 2005 Pg. 50-52	Wish You Were Here: Pharmacy Museum, Weimar, Texas Author(s): Worthen Dennis B
Jan/Feb 2005 Pg. 53-56	Barrier Isolators, Isolators, and Glove Boxes--What's the Difference? Author(s): Rahe Hank
Jan/Feb 2005 Pg. 57	Calculations Author(s): Prince Shelly J
Jan/Feb 2005 Pg. 58-60	Basics of Compounding with Acids Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 61	Standard Operating Procedure: Compounding with Concentrated Acids Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 62	Amitriptyline Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 63	Fentanyl 15-mg/mL Injection, Preservative Free Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 64	Gabapentin 2-mg/mL Injection, Preservative Free Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 65	Guaifenesin 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 66	Lidocaine Hydrochloride-2%, Ketolorac Tromethamine-3%, and Clonidine Hydrochloride-0.1% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 67	Naltrexone Hydrochloride 1.4-mg/mL Injection, Preservative Free Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 68	Naproxen Sodium 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 69	Phenol 8% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 70	Tolazoline Hydrochloride 25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 71	Tramadol Hydrochloride 50-mg/mL Injection, Preservative Free Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 72-74	Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature Author(s): Gupta Vishnu D
Jan/Feb 2005 Pg. 75-81	Physical characteristics of selected over-the-counter medications Author(s): Al-Achi Antoine, Shipp Shawnte
Jan/Feb 2005 Pg. 87	Scientific and Professional Reviewers for 2004 Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 88	PostScription: Pharmacy, Pharmacists, and Pharmacy Practice Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 82-86	Stability of an Extemporaneously Compounded Propylthiouracil Suspension Author(s): Alexander Kenneth S, Mitra Pallabi
Mar/Apr 2005 Pg. 90	Prescription: Too Much Information? Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 93	Book Review: Bacteria for Breakfast: Probiotics for Good Health Author(s): Reed-Kane Dana
Mar/Apr 2005 Pg. 93-94	Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer Author(s): Reed-Kane Dana
Mar/Apr 2005 Pg. 94-97	Literature Reviews Author(s): Foy Elizabeth, MacCara Mary E
Mar/Apr 2005 Pg. 99-103	N-acetylcysteine Used to Decrease the Incidence of Contrast-Induced Nephropathy Following Radiographic Procedures: A Literature Review Author(s): McElhiney Linda F
Mar/Apr 2005 Pg. 105-108	Treatment of Mercury Intoxication With Dimercaptopropanesulfonate Author(s): Smith Barry, Golden Patrick, Pingree Carrie
Mar/Apr 2005 Pg. 140-144	Basics of Compounding for Hair Care--Part I: Medicated Shampoos Author(s): Fonseca Simonne C
Mar/Apr 2005 Pg. 145	Standard Operating Procedure: SOP Master Book--Maintenance Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 146	Calculations Author(s): Prince Shelly J
Mar/Apr 2005 Pg. 147	Aspirin 30-mg/mL Desensitization Oral Liquid, Nonaqueous Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 148	Capsaicin 0.2-mg Troches Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 149	Clobetasol Topical Spray Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 150	Clobetasol and Dyclonine Oral Paste Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 151	Homatropine 3-mg Rapid Dissolving Tablets Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 111-115	What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities Author(s): Collier Kathleen, Beard Janet
Mar/Apr 2005 Pg. 117-119	Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure Author(s): Harrington Catherine A, Cauffield Jacintha
Mar/Apr 2005 Pg. 120-125 View Sample	Use of Domperidone as a Prokinetic and Antiemetic Author(s): Albright Lisa M
Mar/Apr 2005 Pg. 127-130	Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Author(s): Newton David W
Mar/Apr 2005 Pg. 133-134	Communication Makes It or Breaks It Author(s): Roberts Jerrod L
Mar/Apr 2005 Pg. 136-138	Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations Author(s): Kupiec Thomas C
Mar/Apr 2005 Pg. 152	Isosorbide Dinitrate 0.1% Topical Spray Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 153	Sildenafil 1% Vaginal Cream or Gel Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 154	Sildenafil Vaginal Suppository Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 155	Silver Sulfadiazine 1% and Fluriprofen 2% Cream Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 156	Thiabendazole 15% Cream Author(s): Allen Loyd V Jr
Mar/Apr 2005 Pg. 157-164	In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride Author(s): Glowiak Dana L, Green Julie L, Bowman Bill J
Mar/Apr 2005 Pg. 165-166	Chemical Stability of Isoniazid in an Oral Liquid Dosage Form Author(s): Gupta Vishnu D, Sood Arun
Mar/Apr 2005 Pg. 167	PostScription: Experts Everywhere Author(s): Rahe Hank
May/Jun 2005 Pg. 170	PreScription: Working Together: Lessons from a Rope Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 173	Book Reviews: Veterinary Drug Handbook: Client Information Edition Author(s): Reed-Kane Dana
May/Jun 2005 Pg. 173	Book Reviews: When Change Is Your Company's Middle Name: The Professional's Guide to Understanding the Human Side of Business Transformation Author(s): Reed-Kane Dana
May/Jun 2005 Pg. 174-176	Literature Reviews Author(s): Foy Elizabeth, MacCara Mary E
May/Jun 2005 Pg. 178-182 View Sample	Update on Transdermals for Animal Patients Author(s): Davidson Gigi S
May/Jun 2005 Pg. 185-192	Compounding for Behavior Problems in Animals Author(s): Vail Jane, Davidson Gigi S
May/Jun 2005 Pg. 195-198	Compounding Antiangiogenic Cancer Therapy for Animals Author(s): Davidson Gigi S
May/Jun 2005 Pg. 201-205	Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Author(s): Harrington Catherine A, Cauffield Jacintha
May/Jun 2005 Pg. 207	Quality-Control Analytical Methods: Determination of Tapped Bulk Volume for Compounded Prescriptions Author(s): Al-Achi Antoine, Siddoju Srujana
May/Jun 2005 Pg. 209-211	Survey of State Veterinary Compounding Laws and Regulations Author(s): Goodrum Jennifer
May/Jun 2005 Pg. 213-214	What Customers Want Author(s): Roberts Jerrod L
May/Jun 2005 Pg. 215-218	Basics of Compounding for Hair Care -- Part 2: Medicated Conditions Author(s): Fonseca Simonne C
May/Jun 2005 Pg. 220-221	Pharmacy History: Pharmacy Knots Author(s): Worthen Dennis B
May/Jun 2005 Pg. 222-223	Standard Operating Procedure: Exhaust System Airflow Monitoring (Individual Capsule Stations) Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 224	Calculations Author(s): Prince Shelly J
May/Jun 2005 Pg. 225	Calcitriol 100 ng/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 226	Dexamethasone Oral Powder 10-mg Units, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 227	Dipyrone 500-mg/mL Injection, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 228	Meloxicam 0.2 mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 229	Methimazole 10-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 230	Metronidazole 1% and Silver Sulfadiazine 1% Cream, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 231	Pergolide 500-mcg Capsules, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 232	Pergolide 0.2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 233	Phenoxybenzamine Hydrochloride 5-mg Capsules, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 234	Piroxicam 2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 247-248	PostScription: AVMA's Position on Compounding for Animals Author(s): Riddell M Gatz
May/Jun 2005 Pg. 235-237	Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
May/Jun 2005 Pg. 238-241	Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
May/Jun 2005 Pg. 242-246	Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
Jul/Aug 2005 Pg. 250	Prescription: Support Your Local College of Pharmacy Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 252	Book Reviews: Awakening Athena: Resilience, Restoration, and Rejuvenation for Women Author(s): Reed-Kane Dana, Grajeda Betty Jo
Jul/Aug 2005 Pg. 253-254	Book Reviews: Perfect Balance Author(s): Reed-Kane Dana, Grajeda Betty Jo
Jul/Aug 2005 Pg. 254-257	Literature Reviews Author(s): Foy Elizabeth, MacCara Mary E
Jul/Aug 2005 Pg. 259-264 View Sample	Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome Author(s): Tan Robert S
Jul/Aug 2005 Pg. 266	Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy Author(s): White Irene Q
Jul/Aug 2005 Pg. 268-273	Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement Author(s): Milner Martin
Jul/Aug 2005 Pg. 275-278	Compounding for Endocrine Disorders in Adult Patients Author(s): Grajeda Betty Jo, Vail Jane
Jul/Aug 2005 Pg. 281-282	Natural Progesterone Handout Author(s): Kuntz Rachael
Jul/Aug 2005 Pg. 293-298	Local Ventilation for Safe Containment in the Pharmaceutical Industry Author(s): Walters Douglas B, Ryan Ray
Jul/Aug 2005 Pg. 307-308	Calculations Author(s): Prince Shelly J
Jul/Aug 2005 Pg. 309	Standard Operating Procedure: Employee Personnel Records Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 310	BMS Mouthwash Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 311	Bonain's Solution Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 312	Brompton's Mixture Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 284-290	Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Author(s): Wagner James T
Jul/Aug 2005 Pg. 300-302	Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding Author(s): Kupiec Thomas C, Okeke Claudia, Allen Loyd V Jr, Denison Clay
Jul/Aug 2005 Pg. 303-306	Basics of Pharmacogenomics for the Compounding Pharmacist Author(s): Kupiec Thomas C, Raj Vishnu
Jul/Aug 2005 Pg. 313	Bunnel's Solutions Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 314	Burow's Solution Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 315	Joulie's Solution Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 316	Shohl's Solution, Modified (Albright's Solution) Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 317	Suby-Albright Solution "G" Irrigation Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 318	Suby-Albright Solution "M" Irrigation Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 319	Whitehead's Varnish Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 320-322	Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Author(s): Trissel Lawrence A, Zhang Yanping
Jul/Aug 2005 Pg. 323-326	Stability of Nebulizer Admixtures Author(s): Blondino Frank E, Baker Matthew
Jul/Aug 2005 Pg. 327-328	PostScription: Women in Balance: A Cause Worth Advancing Author(s): Murray Jane, Reilly Colleen
Sep/Oct 2005 Pg. 330	Prescription: Pharmacy Compounding Worldwide Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 332-333	Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America Author(s): Reed-Kane Dana
Sep/Oct 2005 Pg. 333-336	Literature Reviews Author(s): Foy Elizabeth, MacCara Mary E
Sep/Oct 2005 Pg. 339-346	Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Author(s): Mishkan Emilyn S
Sep/Oct 2005 Pg. 349-352	Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 354	A Patient's Guide to Transdermal Treatment of Pain Author(s): Fields Shannon W
Sep/Oct 2005 Pg. 357-358 View Sample	Formulating for the Gluten-sensitive Individual Author(s): Cacace Janice L
Sep/Oct 2005 Pg. 361-362	Basics of Compounding: Using Chemical Conversion Factors Author(s): Fonseca Simonne C
Sep/Oct 2005 Pg. 364-367	Compounding: A Well-established Practice in 1938 Author(s): Houck Larry K
Sep/Oct 2005 Pg. 382-383	Standard Operating Procedure: Denver Instrument Company M-120 Analytical Balance--Calibration, Cleaning, and Use Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 369-378	Technology Update: An Overview of PDA-based Software Applications for Practicing Pharmacists Author(s): Khandelwal Kikhil G, Felkey Bill G
Sep/Oct 2005 Pg. 380-381	Back to the Basics of Business Author(s): Waddill Russell A
Sep/Oct 2005 Pg. 384-385	Calculations Author(s): Prince Shelly J
Sep/Oct 2005 Pg. 386	Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 387	Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 388	Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 389	Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 390	Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 391	Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 392	Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 393	Methadone Hydrochloride 0.33-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 394	Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 395	Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 396-298	Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration Author(s): Landry Christine, Forest Jean-Marc, Hildgen Patrice
Sep/Oct 2005 Pg. 399-401	Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion Author(s): Gupta Vishnu D
Sep/Oct 2005 Pg. 402-406	Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations Author(s): Sidhom Madiha B, Rivera Nadya, Almoazen Hassan, Taft David R, Kirschenbaum Harold L
Sep/Oct 2005 Pg. 407-408	PostScription: Searching for Barrier Isolator Information? Author(s): Fink Carl, Newman John
Nov/Dec 2005 Pg. 410	Prescription: Pediatric Formulation Initiatives Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 413-420	Unlocking Autism: Is Compounding the Key? Author(s): Vail Jane
Nov/Dec 2005 Pg. 423-431	Compounding for a Pediatric Hospital Author(s): McElhiney Linda F
Nov/Dec 2005 Pg. 433-434 View Sample	Wiping Out Diaper Rash Author(s): Fields Shannon W
Nov/Dec 2005 Pg. 437-442	Pediatric Oral Liquid Preparations Author(s): Fonseca Simonne C, Ferreira Anderson de O
Nov/Dec 2005 Pg. 445-447	Marketing Your Business for Success Author(s): Waddill Russell A
Nov/Dec 2005 Pg. 449-451	Compounding Around the World: Portugal Author(s): Carvalho Maria Joao
Nov/Dec 2005 Pg. 452-455	Profile: The McGuff Companies. Part 1: Compounding and Manufacturing Share Facilities and Build Corporate Success Author(s): Vail Jane
Nov/Dec 2005 Pg. 470	Standard Operating Procedure: Washing Glassware and Equipment Used in Compounding Nonsterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 471	Calculations Author(s): Prince Shelly J
Nov/Dec 2005 Pg. 472	Alprazolam 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 473	Bethanechol 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 474	Clonazepam 0.1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 475	Dolasetron 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 476	Ganciclovir 100-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 477	Isradipine 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 456-461	Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Author(s): Fonseca Simonne C
Nov/Dec 2005 Pg. 462-469	Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 478	Pyrazinamide 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 479	Quinidine Sulfate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 480	Ursodiol 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 481	Valganciclovir Hydrochloride 60-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 482-483	Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags Author(s): Donnelly Ronald F
Nov/Dec 2005 Pg. 484-486	Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Nov/Dec 2005 Pg. 487-488	PostScription: Compounding Pharmacies and the Successful Treatment of Autism Author(s): Neurander James A